Lars Kaiser
Impact in
-
- Heavy Metal Exposure and Toxicity
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
Papers in
-
- Sphingolipid Metabolism and Signaling 2
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Hans‐Peter Deigner (17 shared papers)Matthias Kohl (5 shared papers)Ralf Kinscherf (2 shared papers)René Csük (9 shared papers)Markus Blaess (5 shared papers)Martin Sauer (1 shared paper)Stefan Laufer (4 shared papers)Silke Laßmann (1 shared paper)
- Journals
- International Journal of Molecular Sciences (4 papers)Scientific Reports (2 papers)Applied Sciences (1 paper)Frontiers in Pharmacology (1 paper)Nanomedicine Nanotechnology Biology and Medicine (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Lars Kaiser
24 papers receiving 411 citations
Peers
Comparison fields: 5 of 110
- Health, Toxicology and Mutagenesis 48
- Infectious Diseases 58
- Applied Microbiology and Biotechnology 6
- Molecular Medicine 14
- Molecular Biology 177
Countries citing papers authored by Lars Kaiser
This map shows the geographic impact of Lars Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Kaiser more than expected).
Fields of papers citing papers by Lars Kaiser
This network shows the impact of papers produced by Lars Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Kaiser. The network helps show where Lars Kaiser may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Kaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 115 | |
| 2 | 2018 | 62 | |
| 3 | 2021 | 47 | |
| 4 | 2020 | 43 | |
| 5 | 2021 | 33 | |
| 6 | 2020 | 22 | |
| 7 | 2017 | 21 | |
| 8 | 2021 | 17 | |
| 9 | 2021 | 13 | |
| 10 | 2024 | 6 | |
| 11 | 2021 | 6 | |
| 12 | 2020 | 6 | |
| 13 | 2024 | 5 | |
| 14 | 2025 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2020 | 3 | |
| 18 | 2022 | 2 | |
| 19 | 2017 | 2 | |
| 20 | 2021 | 2 |
About Lars Kaiser
Lars Kaiser is a scholar working on Molecular Biology, Infectious Diseases, Genetics, Critical Care and Intensive Care Medicine and Clinical Biochemistry, having authored 28 papers that have together received 427 indexed citations. Recurring topics across this work include Intensive Care Unit Cognitive Disorders (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Biosensors and Analytical Detection (2 papers), Sphingolipid Metabolism and Signaling (2 papers), Neurogenetic and Muscular Disorders Research (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), COVID-19 Clinical Research Studies (2 papers) and Analytical chemistry methods development (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (48 citations), Infectious Diseases (58 citations), Applied Microbiology and Biotechnology (6 citations), Molecular Medicine (14 citations) and Molecular Biology (177 citations). Lars Kaiser has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Hans‐Peter Deigner, Matthias Kohl, Ralf Kinscherf, René Csük, Markus Blaess, Martin Sauer, Stefan Laufer, Silke Laßmann, Andrew J. McCluskey and Manfred Jung. Their work appears in journals such as International Journal of Molecular Sciences, Scientific Reports, Applied Sciences, Frontiers in Pharmacology and Nanomedicine Nanotechnology Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.